ELETRIPTAN Drug Patent Profile

Which patents cover Eletriptan, and what generic alternatives are available?

Eletriptan is a drug marketed by Annora Pharma, Aurobindo Pharma, Carlsbad, Chartwell Rx, Mylan, Regcon Holdings, Stevens J, Teva Pharms Usa, and Zydus Pharms. and is included in nine NDAs.

The generic ingredient in ELETRIPTAN is eletriptan hydrobromide. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the eletriptan hydrobromide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Eletriptan

A generic version of ELETRIPTAN was approved as eletriptan hydrobromide by ZYDUS PHARMS on June 16^th, 2017.

Summary for ELETRIPTAN

US Patents:	0
Applicants:	9
NDAs:	9
Drug Prices:	Drug price information for ELETRIPTAN
What excipients (inactive ingredients) are in ELETRIPTAN?	ELETRIPTAN excipients list
DailyMed Link:	ELETRIPTAN at DailyMed

See drug prices for ELETRIPTAN

US Patents and Regulatory Information for ELETRIPTAN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Annora Pharma	ELETRIPTAN HYDROBROMIDE	eletriptan hydrobromide	TABLET;ORAL	219143-001	Jul 7, 2025	AB	RX	No	No
Zydus Pharms	ELETRIPTAN HYDROBROMIDE	eletriptan hydrobromide	TABLET;ORAL	206409-002	Jun 16, 2017	AB	RX	No	No
Chartwell Rx	ELETRIPTAN HYDROBROMIDE	eletriptan hydrobromide	TABLET;ORAL	205186-001	Aug 29, 2017	AB	RX	No	No
Aurobindo Pharma	ELETRIPTAN HYDROBROMIDE	eletriptan hydrobromide	TABLET;ORAL	210708-002	Jan 15, 2019	AB	RX	No	No
Regcon Holdings	ELETRIPTAN HYDROBROMIDE	eletriptan hydrobromide	TABLET;ORAL	215467-002	Jul 13, 2022	AB	RX	No	No
Chartwell Rx	ELETRIPTAN HYDROBROMIDE	eletriptan hydrobromide	TABLET;ORAL	205186-002	Aug 29, 2017	AB	RX	No	No
Teva Pharms Usa	ELETRIPTAN HYDROBROMIDE	eletriptan hydrobromide	TABLET;ORAL	202040-002	Jun 27, 2017	AB	RX	No	No